UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rationale for Increasing Doses of Statins in Everyday Clinical Practice

Kardiologiia, 2024-08, Vol.64 (8), p.79-88

Susekov, A V

2024

Volltextzugriff (PDF)

Lipid-lowering Eeficacy and Safety of High Doses of Atorvastatin and Rosuvastatin

Kardiologiia, 2023-02, Vol.63 (2), p.59-67

Susekov, A V

2023

Volltextzugriff (PDF)

Statin-induced rhabdomyolysis in a 60-year-old woman with decompensated type 2 diabetes: a case report

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2021-12, Vol.26 (11), p.4471

2021

Volltextzugriff (PDF)

Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts

Kardiologiia, 2019-06, Vol.59 (5S), p.47-57

2019

Volltextzugriff (PDF)

Modern algorithms for statin therapy

Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2023-09, Vol.28 (10), p.5594

Susekov, V. A.

2023

Volltextzugriff (PDF)

Lipid-lowering Eeficacy and Safety of High Doses of Atorvastatin and Rosuvastatin

Kardiologiia, 2023-02, Vol.63 (2), p.59-67

Susekov, A V

2023

Volltextzugriff (PDF)

Evidence-based grounds of the efficacy of simvastatin (zocor): 15 years later

Terapevtic̆eskii arhiv, 2010-01, Vol.82 (12), p.68

2010

Volltextzugriff (PDF)

Homozygous familial hypercholesterolemia: modern aspects of pathogenesis, diagnostics and treatment

Medical Council, 2018-10 (17), p.253-259

2018

Volltextzugriff (PDF)

Omega-3 Polyunsaturated Fatty Acids in Patients with Hypertriglyceridemias and Atherosclerosis

Kardiologiia, 2021-07, Vol.61 (6), p.88-96

Susekov, A. V.

2021

Volltextzugriff (PDF)

Omega-3 Polyunsaturated Fatty Acids in Patients with Hypertriglyceridemias and Atherosclerosis

Kardiologiia, 2021-07, Vol.61 (6), p.88-96

Susekov, A V

2021

Volltextzugriff (PDF)

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY

Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 2016-01, Vol.6 (3), p.345-348

2016

Volltextzugriff (PDF)

Ezetimib--inhibitor of cholesterol absorption: new perspectives in the treatment of dyslipidemia

Terapevtic̆eskii arhiv, 2005, Vol.77 (8), p.24

Susekov, A V

2005

Volltextzugriff (PDF)

Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)

Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika, 2012-01, Vol.11 (4), p.70-78

2012

Volltextzugriff (PDF)

Statin therapy and atherosclerosis stabilization in carotid arteries

CardioSomatika, 2015-03, Vol.6 (1), p.36-45

2015

Volltextzugriff (PDF)

Atorvastatin: evidence base 15 years later

Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika, 2011-06, Vol.10 (3), p.103-112

2011

Volltextzugriff (PDF)

Perspectives of the use of fenofibrate in patients with type 2 diabetes mellitus: what is new after the ACCORD Study?

Kardiologiia, 2011, Vol.51 (9), p.68

2011

Volltextzugriff (PDF)

LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE

Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 2011-01, Vol.7 (2), p.231-240

2011

Volltextzugriff (PDF)

STATINS IN PREVENTION OF ISCHEMIC STROKE

Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 2013-01, Vol.9 (4), p.409-416

2013

Volltextzugriff (PDF)

Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines

Kardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika, 2011-01, Vol.10 (6), p.81-88

2011

Volltextzugriff (PDF)

P2.05 Arterial Wall Function in Patients with Coronary Heart Disease and Dyslipidemia, Comparative Efficacy of Ezetimibe, Statins and Their Combination

Artery research, 2010-12, Vol.4 (4), p.157-158

2010

Volltextzugriff (PDF)

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY

Rat͡s︡ionalʹnai͡a︡ farmakoterapii͡a︡ v kardiologii, 2010-01, Vol.6 (4), p.447-454

2010

Volltextzugriff (PDF)

Inhibitors of HMG-Co-A reductase (statins) in the treatment of dyslipidemia and atherosclerosis at the turn of decades

Kardiologiia, 2010, Vol.50 (12), p.84

2010

Volltextzugriff (PDF)

Lipid metabolism disorders and thyrotoxicosis

Rossiĭskiĭ vestnik perinatologii i pediatrii, 2021-01, Vol.65 (6), p.91-97

2021

Volltextzugriff (PDF)

Practical aspects of "Heart Protection Studies"

Terapevtic̆eskii arhiv, 2004, Vol.76 (2), p.91

Susekov, A V

2004

Volltextzugriff (PDF)

Simvastatin in management of patients with primary hypercholesterolemia: tolerability and efficacy of daily doses 10-80 mg

Kardiologiia, 2002, Vol.42 (1), p.33

2002

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(76)

Sprache

Englisch
(41)
Russisch
(40)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rationale for Increasing Doses of Statins in Everyday Clinical Practice

Lipid-lowering Eeficacy and Safety of High Doses of Atorvastatin and Rosuvastatin

Statin-induced rhabdomyolysis in a 60-year-old woman with decompensated type 2 diabetes: a case report

Possibilities of clinical use of ezetimibe Otrio (JSC "AKRIKHIN", Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts

Modern algorithms for statin therapy

Lipid-lowering Eeficacy and Safety of High Doses of Atorvastatin and Rosuvastatin

Evidence-based grounds of the efficacy of simvastatin (zocor): 15 years later

Homozygous familial hypercholesterolemia: modern aspects of pathogenesis, diagnostics and treatment

Omega-3 Polyunsaturated Fatty Acids in Patients with Hypertriglyceridemias and Atherosclerosis

Omega-3 Polyunsaturated Fatty Acids in Patients with Hypertriglyceridemias and Atherosclerosis

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFULTRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED FLUVASTATIN EXTENDED RELEASE ADDED TO STANDARD THERAPY. PROTOCOL OF THE OPEN-LABEL OBSERVATIONAL STUDY

Ezetimib--inhibitor of cholesterol absorption: new perspectives in the treatment of dyslipidemia

Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study)

Statin therapy and atherosclerosis stabilization in carotid arteries

Atorvastatin: evidence base 15 years later

Perspectives of the use of fenofibrate in patients with type 2 diabetes mellitus: what is new after the ACCORD Study?

LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE

STATINS IN PREVENTION OF ISCHEMIC STROKE

Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the levels of C-reactive protein and proinflammatory cytokines

P2.05 Arterial Wall Function in Patients with Coronary Heart Disease and Dyslipidemia, Comparative Efficacy of Ezetimibe, Statins and Their Combination

QUALITY OF LIFE AND COMPLIANCE TO THERAPY IN PATIENTS FOLLOWING SUCCESSFUL TRANSLUMINAL CORONARY ANGIOPLASTY, WHO WERE PRESCRIBED LESCOL XL (FLUVASTATIN) ADDED TO STANDARD THERAPY. RESULTS OF THE LESQOL OPEN-LABEL OBSERVATIONAL STUDY

Inhibitors of HMG-Co-A reductase (statins) in the treatment of dyslipidemia and atherosclerosis at the turn of decades

Lipid metabolism disorders and thyrotoxicosis

Practical aspects of "Heart Protection Studies"

Simvastatin in management of patients with primary hypercholesterolemia: tolerability and efficacy of daily doses 10-80 mg

Suchergebnisse filtern